What is the current PDSB ATM implied volatility?

As of Oct 13, 2026, PDS Biotechnology Corporation (PDSB) at-the-money implied volatility is 216.3%. IV rank is 84.9% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.

Is PDSB IV high or low historically?

IV is elevated relative to its 1-year history, conditions that typically favor premium-selling strategies (credit spreads, iron condors, covered calls).

What does PDSB volatility skew tell options traders?

Volatility skew is the pattern by which IV varies across strikes for a given expiration. PDS Biotechnology Corporation carries the typical equity downside-protection skew: 25-delta puts price meaningfully richer than 25-delta calls. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.

PDS Biotechnology Corporation (PDSB) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

PDS Biotechnology Corporation (PDSB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $89.5M, listed on NASDAQ, employing roughly 21 people, carrying a beta of 1.45 to the broader market. PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Led by Frank K. Bedu-Addo, public since 2015-09-30.

Snapshot as of Oct 13, 2026.

Spot Price: $1.58
ATM IV: 216.3%
IV Skew 25Δ: -0.709
IV Rank: 84.9%
IV Percentile: 98.0%
Term Structure Slope: -0.368

As of Oct 13, 2026, PDS Biotechnology Corporation (PDSB) at-the-money implied volatility is 216.3%. IV rank is 84.9% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 98.0%. The 25-delta skew is -0.709: puts carry meaningful premium over calls, a classic equity downside-protection skew. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.

PDSB Strategy Selection at Current Volatility Levels

For PDS Biotechnology Corporation options at 216.3% ATM IV, high IV rank (84.9%) favors premium-selling structures: credit spreads, iron condors, covered calls, cash-secured puts. The risk: a continued vol expansion through high-rank levels is rare but expensive when it happens. The 25-delta skew is meaningfully put-skewed, so put-credit spreads capture more premium for the same width than call-credit spreads. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.

How to read the PDSB volatility surface

ATM IV currently prints at 216.3%, 84.9% IV rank, against 295.3% realized over the trailing 20 trading days. Implied is currently below realized by 78.9 vol points, an inverted regime where premium buyers are underpaying for the move - rare and often a setup for IV expansion. The 25-delta skew is meaningfully put-skewed at -0.709, meaning out-of-the-money puts are bid up relative to equivalent-delta calls - the classic equity-tail-risk pricing pattern. The term-structure slope of -0.368 is inverted (backwardation) - near-dated IV trades above longer-dated, signaling acute near-term event risk.

PDSB IV rank and the variance risk premium

PDSB sits in the top quartile of its 1-year IV range (rank 84.9%). High-IV-rank regimes are statistically the best premium-selling environments - covered calls, cash-secured puts, credit spreads, and iron condors all collect more premium for the same notional risk. The risk: a continued vol expansion through high-rank levels is rare but very expensive when it happens; size positions to the implied move, not the historical range. Compared with 60-day realized HV of 309.3%, current ATM IV is 92.9 vol points cheap.

Trading vol on PDSB: practical notes

The variance risk premium - the persistent gap between implied and subsequently realized volatility - is positive on equity-market averages, which is why premium-selling carries a long-run edge. But the edge is averaged across a distribution; individual realizations can blow past the implied move in either direction. PDSB front-month expiration sits at 31 days; near-dated structures get the highest theta decay but also the largest gamma sensitivity, so the same vol-rank read translates into very different structures at 7 DTE vs 45 DTE. Pair the rank read with the dealer-gamma view, the term-structure shape, and the upcoming-event calendar to confirm the trade fits both the structural regime and the path-dependent risk. Risk-defined structures (credit/debit spreads, condors, butterflies) are usually safer than naked positions when the regime is uncertain.

PDSB volatility surface: linking strikes to tenors

Skew across strikes and the term structure across expirations together describe the PDSB implied-volatility surface - the two-dimensional grid of IV across strike and expiration that determines every option premium on the chain. Currently the 25-delta skew is -0.709 and the term-structure slope is -0.368, a combination that flags acute near-term concern: put-skewed AND backwardated means both the strike and the tenor dimensions are pricing risk. Term structure tells you when the market expects the action; skew tells you which direction. Combined with the 84.9% IV rank, the surface gives a complete read on whether PDSB options are cheap, fair, or expensive across both dimensions. Practitioners watch surface dynamics (skew steepening, term-structure inversion) alongside level (IV rank) - level moves are common but surface shape changes typically signal regime-level shifts in how the chain is being positioned.

For PDSB specifically, the surface read fits into a broader options-trading toolkit. Single-leg directional positions (long calls or puts) depend almost entirely on level: cheap IV at any skew/term shape favors buyers, rich IV favors sellers. Risk-defined spreads (vertical credit/debit spreads, iron condors, butterflies) depend on both level and skew: put-skewed surfaces make put-side credit spreads collect more premium per width than call-side, and the asymmetry can compound or offset the directional thesis. Calendar and diagonal spreads depend on term shape: contango makes long-back-month / short-front-month structures cheaper to put on but harder to harvest theta from quickly. Pair the surface read with the dealer-gamma view, the upcoming-event calendar, and the underlying-trend context to choose the strike, the tenor, and the structure family that match both the regime and the conviction level.

Learn how volatility skew is reported and how to read the data →

ATM implied volatility at each listed expiration. Front-month points sit at the left; longer-dated tenors extend right. Upward-sloping curves indicate contango (calmer near-term, more uncertainty further out); downward-sloping indicates backwardation (acute near-term stress).

Frequently asked PDSB volatility skew questions

What is the current PDSB ATM implied volatility?: As of Oct 13, 2026, PDS Biotechnology Corporation (PDSB) at-the-money implied volatility is 216.3%. IV rank is 84.9% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
Is PDSB IV high or low historically?: IV is elevated relative to its 1-year history, conditions that typically favor premium-selling strategies (credit spreads, iron condors, covered calls).
What does PDSB volatility skew tell options traders?: Volatility skew is the pattern by which IV varies across strikes for a given expiration. PDS Biotechnology Corporation carries the typical equity downside-protection skew: 25-delta puts price meaningfully richer than 25-delta calls. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.